CA2259997C - Medicaments pour la prevention/le traitement de la stomatite - Google Patents

Medicaments pour la prevention/le traitement de la stomatite Download PDF

Info

Publication number
CA2259997C
CA2259997C CA002259997A CA2259997A CA2259997C CA 2259997 C CA2259997 C CA 2259997C CA 002259997 A CA002259997 A CA 002259997A CA 2259997 A CA2259997 A CA 2259997A CA 2259997 C CA2259997 C CA 2259997C
Authority
CA
Canada
Prior art keywords
carnosine
stomatitis
zinc
sodium alginate
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002259997A
Other languages
English (en)
Other versions
CA2259997A1 (fr
Inventor
Masaaki Hirano
Shirou Katayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hamari Chemicals Ltd
Zeria Pharmaceutical Co Ltd
Original Assignee
Hamari Chemicals Ltd
Zeria Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP19164096A external-priority patent/JP3877807B2/ja
Application filed by Hamari Chemicals Ltd, Zeria Pharmaceutical Co Ltd filed Critical Hamari Chemicals Ltd
Publication of CA2259997A1 publication Critical patent/CA2259997A1/fr
Application granted granted Critical
Publication of CA2259997C publication Critical patent/CA2259997C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Médicaments pour la prévention/le traitement de la stomatite, contenant un sel de L-zinc-carnosinate ou un complexe L-carnosine/zinc, associé éventuellement à de l'alginate de sodium. Ces médicaments sont très efficaces pour traiter et prévenir la stomatite, notamment celle provoquée par une chimiothérapie ou une radiothérapie anticancéreuse.
CA002259997A 1996-07-03 1997-06-25 Medicaments pour la prevention/le traitement de la stomatite Expired - Fee Related CA2259997C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19164096A JP3877807B2 (ja) 1996-07-03 1996-07-03 口内炎治療・予防剤
JP8/191640 1996-07-03
PCT/JP1997/002192 WO1998001146A1 (fr) 1996-07-03 1997-06-25 Medicaments pour la prevention/le traitement de la stomatite

Publications (2)

Publication Number Publication Date
CA2259997A1 CA2259997A1 (fr) 1998-01-15
CA2259997C true CA2259997C (fr) 2006-02-21

Family

ID=35985387

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002259997A Expired - Fee Related CA2259997C (fr) 1996-07-03 1997-06-25 Medicaments pour la prevention/le traitement de la stomatite

Country Status (1)

Country Link
CA (1) CA2259997C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016210409A1 (fr) * 2015-06-26 2016-12-29 Di Rocco Richard J Formulations de l-carnosine et de zinc et méthodes d'utilisation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016210409A1 (fr) * 2015-06-26 2016-12-29 Di Rocco Richard J Formulations de l-carnosine et de zinc et méthodes d'utilisation

Also Published As

Publication number Publication date
CA2259997A1 (fr) 1998-01-15

Similar Documents

Publication Publication Date Title
US4965252A (en) Cholesterol-lowering combination compositions of guar gum and niacin
KR0148589B1 (ko) 항종양 효과의 상승 및 종양의 치료를 위한 조성물 및 키트
US4446140A (en) Method and composition for treating mouth pain
US4870061A (en) Use of N-acetylglucosamine for the therapy of degenerative joint disease and related diseases
PL209943B1 (pl) Zastosowanie moksifloksacyny stanowiącej kwas 1-cyklopropylo-6-fluoro-1,4-dihydro-8-metoksy-7-[(4aS,7aS)-oktahydro-6H-pirolo [3,4-b]pirydyn-6-ylo]-4-okso-3-chinolino-karboksylowy
US5006551A (en) Composition for destroying malignant tumors
CA2018945A1 (fr) Sucralfate et un medicament et methodes de preparation
AU713337B2 (en) Remedies and preventives for stomatitis
JPS63239227A (ja) 薬剤組成物およびその使用
EP1366768B1 (fr) Compositions à usage thérapeutique comprenant de la vitamine C, un sel métallique fournissant des ions Ca, de l'insuline, un extract de camomille, de la vitamine B et une antihistamine
EP1033129B1 (fr) Produits antimicrobiens pour traiter l'ulcère peptique
CA2259997C (fr) Medicaments pour la prevention/le traitement de la stomatite
KR0147855B1 (ko) 골형성 촉진제
US5116600A (en) Composition and method for inhibiting inflammation caused by non-parenteral administration of 5-fluorouracil type compounds
JP3561764B2 (ja) 呼吸器系疾患治療薬
IE61381B1 (en) Topically applied gold organic complex
JPWO2006043336A1 (ja) 胃粘膜疾患の治療又は予防のための組成物
IE58434B1 (en) Inhibition of tumor development
RU2751351C2 (ru) Пероральный препарат ибупрофена
JPS61134315A (ja) 解熱鎮痛剤
JP2002265354A (ja) 抗ピロリ菌剤組成物
KR0185331B1 (ko) 위장질환치료제
JP2000016949A (ja) 口内炎、消化管粘膜障害又は皮膚潰瘍の治療又は予防剤
JPS62174020A (ja) 急性胃炎治療剤
GB1582666A (en) Treatment of malignant conditions with mandelic acid or derivatives thereof

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160627